Suvankar Banerjee

Pharmacophore-based virtual screening, 3D QSAR, Docking, ADMET, and MD simulation studies: An in silico perspective for the identification of new potential HDAC3 inhibitors

Goverdhan Lanka, Darakhshan Begum, Suvankar Banerjee et al. · Computers in Biology and Medicine · 2023 · 100 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

First structure–activity relationship analysis of SARS-CoV-2 virus main protease (Mpro) inhibitors: an endeavor on COVID-19 drug discovery

Sk. Abdul Amin, Suvankar Banerjee, Samayaditya Singh et al. · Molecular Diversity · 2021 · 54 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Selective HDAC3 Inhibitors with Potent In Vivo Antitumor Efficacy against Triple-Negative Breast Cancer

Sravani Pulya, Ambati Himaja, Milan Paul et al. · Journal of Medicinal Chemistry · 2023 · 53 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Assessing structural insights into in-house arylsulfonyl L-(+) glutamine MMP-2 inhibitors as promising anticancer agents through structure-based computational modelling approaches

Sandip Kumar Baidya, Suvankar Banerjee, Balaram Ghosh et al. · SAR and QSAR in environmental research · 2023 · 46 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

An assessment of crucial structural contributors of HDAC6 inhibitors through fragment-based non-linear pattern recognition and molecular dynamics simulation approaches

Suvankar Banerjee, Sandeep Jana, Tarun Jha et al. · Computational Biology and Chemistry · 2024 · 45 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17